Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials
- PMID: 11595728
Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials
Abstract
Purpose: In the present study, we examined the expression of a multifunctional cytokine, interleukin 8 (IL-8), and its receptors, CXCR1 and CXCR2, in human colon carcinoma cells with different metastatic potentials and determined their role in modulating phenotypes associated with metastasis.
Experimental design: IL-8, CXCR1, and CXCR2 protein and mRNA expression were examined using ELISA, immunocytochemistry, and reverse transcription-PCR in human colon carcinoma cells with different metastatic potentials. IL-8-mediated proliferation, migration, and tumor-endothelial cell interaction were analyzed.
Results: IL-8 mRNA and protein expression was very low in Caco2 cells but elevated in KM12C cells and very high in KM12L4 cells, suggesting an association between the IL-8 production and metastatic potential. Similarly, CXCR1 and CXCR2 expression was lower in Caco2 cells than in low and high metastatic KM12C and KM12L4 cells. The recombinant human IL-8 enhanced the proliferation of colon carcinoma cells. Furthermore, proliferation of low and high metastatic cells expressing different levels of IL-8 was inhibited by neutralizing antibodies to IL-8, CXCR1, and CXCR2. We observed significant differences in the invasive potential of colon carcinoma cells expressing different levels of IL-8. In addition, we observed that IL-8 modulates adhesion of tumor cells to endothelial cells in an autocrine and paracrine manner.
Conclusion: Our present data suggest an association between constitutive expression of IL-8 and aggressiveness in human colon carcinoma cells and the possible role of IL-8 in modulating different metastatic phenotypes associated with progression and metastasis.
Similar articles
-
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.Br J Cancer. 2004 Nov 29;91(11):1970-6. doi: 10.1038/sj.bjc.6602227. Br J Cancer. 2004. PMID: 15545974 Free PMC article.
-
Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis.Angiogenesis. 2005;8(1):63-71. doi: 10.1007/s10456-005-5208-4. Angiogenesis. 2005. PMID: 16132619
-
The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium.J Neuroimmunol. 2005 Apr;161(1-2):49-60. doi: 10.1016/j.jneuroim.2004.12.004. J Neuroimmunol. 2005. PMID: 15748943
-
An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.Mol Biol Rep. 2021 Sep;48(9):6551-6561. doi: 10.1007/s11033-021-06648-8. Epub 2021 Aug 24. Mol Biol Rep. 2021. PMID: 34426905 Review.
-
The CXCL8-CXCR1/2 pathways in cancer.Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25. Cytokine Growth Factor Rev. 2016. PMID: 27578214 Free PMC article. Review.
Cited by
-
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis.J Carcinog. 2011;10:40. doi: 10.4103/1477-3163.92308. Epub 2011 Dec 31. J Carcinog. 2011. PMID: 22368515 Free PMC article.
-
The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells.Br J Pharmacol. 2007 Apr;150(8):977-86. doi: 10.1038/sj.bjp.0707184. Epub 2007 Mar 5. Br J Pharmacol. 2007. PMID: 17339836 Free PMC article.
-
Common denominator genes that distinguish colorectal carcinoma from normal mucosa.Int J Colorectal Dis. 2005 Jul;20(4):353-62. doi: 10.1007/s00384-004-0664-7. Epub 2004 Dec 22. Int J Colorectal Dis. 2005. PMID: 15614505 Clinical Trial.
-
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.Cancer Lett. 2011 Jan 28;300(2):180-8. doi: 10.1016/j.canlet.2010.10.004. Epub 2010 Oct 29. Cancer Lett. 2011. PMID: 21035946 Free PMC article.
-
Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells.Prostate. 2014 Feb;74(2):177-86. doi: 10.1002/pros.22739. Epub 2013 Oct 22. Prostate. 2014. PMID: 24151226 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources